Placeholder text

Go to cart

Assessment of ADRs on ANAs: A Study Done By Indian Pharm D Students

By Joel Thomas

Assessment of ADRs on ANAs: A Study Done By Indian Pharm D Students

By Joel Thomas

- Default Title
Description
The clinical pharmacist in oncology care team has a crucial role in patient care through improving use of chemotherapy and other high alert medications. As part of multidisciplinary team, clinical pharmacist needs to assure safe, effective, cost-effective and more patient-oriented drug therapy. Adverse Drug Reactions are noxious and unintended death causing factor in cancer treatment. Antineoplastic drugs were mostly prescribed for cancer patients, who has greater suspectability towards ADRs. Along with other onco healthcare professionals, clinical pharmacist intervention in the treatment planning of the cancer patients, can identify, detect, assess, educate, monitor, minimize, prevent & manage the ANAs induced ADRs by supportive antidote therapy & palliative care, that can produce a impact by minimize economic burden & improving QOL, which can be sudden & significant, the latter can be particularly important to patients who want to live as normally as possible after diagnosis. The p value of the current study was found to be 0.006 (highly significant). & Chi-square value was 18.04, which shows a directly proportional association b/w ADR probability scores & stages of cancer.
Product details
Binding:
Paperback
Number of Pages:
104
Release Date:
2025-10-17
Publication Date:
2025-10-17
Publisher:
LAP LAMBERT Academic Publishing
Languages:
Original: English
ISBN10:
620887775X
ISBN13:
9786208877750
Weight:
173 g
Height:
150 cm
Width:
220 cm
Thickness:
7 cm
Buy on Amazon
Currently sold out